A mortal case of coronavirus disease in a pregnant diabetic woman. Clinical case
Keywords:pregnancy, COVID-19, infectious diseases, intensive care medicine, gestational diabetes mellitus
Pregnant women are very susceptible to coronavirus infection. Gestational diabetes mellitus is severe comorbidity and a serious risk factor for lethal outcomes. We report a mortal case of coronavirus disease (COVID-19) associated with bilateral pneumonia and systemic inflammatory response syndrome in a pregnant woman with gestational diabetes mellitus.
Patient was admitted to the hospital at 31 weeks of gestation with COVID-19 bilateral pneumonia. Anti-inflammatory, antiviral, antibacterial and immunomodulatory treatment was started. She received per os favipiravir 200 mg, azithromycin 500 mg, enfluvir 75 mg, plaquenil 200 mg, and ceftriaxone 1 g intravenously, piperacillin 4.5 g intravenously, methylprednisolone 40 mg intramuscular, enoxaparin 0.6 subcutaneously. The doses of insulin were changed. But maternal status became worse in several hours. Oxygen saturation dropped to 80%. Patient was intubated and connected to the artificial lung ventilator. The cesarean was performed. The preterm born baby with early neonatal sepsis diseased the next day. The treatment could not counteract an inflammatory storm. Despite intensive resuscitation, the woman diseased.
The fatal case of COVID-19 was associated with coexisted gestational diabetes mellitus and late admission to the hospital. The COVID-19 patients with gestational diabetes mellitus are at higher risk of severe pneumonia, systemic inflammatory response and carbohydrate metabolism decompensation. Oxidative stress caused by bilateral pneumonia initiated the chain of tissue injury-related reactions. The fat tissue is an additional source of free radicals and proinflammatory cytokines. Progression of the proinflammatory scenario enhanced multiple organ failure. We have found signs of acute pulmonary, hepatic, and renal insufficiency. The unresponsiveness to treatment contributed to systemic inflammatory response and maternal deterioration.
Further investigations are necessary to improve outcomes in COVID-19 during pregnancy.
Panahi, L., Amiri, M., Pouy, S. “Risks of Novel Coronavirus Disease (COVID-19) in Pregnancy; a Narrative Review.” Arch Acad Emerg Med 8.1 (2020): e34. eCollection 2020.
Mullins, E., Evans, D., Viner, R.M., et al. “Coronavirus in pregnancy and delivery: rapid review.” Ultrasound Obstet Gynecol (2020). DOI: 10.1002/uog.22014
Rasmussen, S.A., Smulian, J.C., Lednicky, J.A., et al. “Coronavirus Disease 2019 (COVID-19) and Pregnancy: What obstetricians need to know.” Am J Obstet Gynecol (2020). DOI: 10.1016/j.ajog.2020.02.017
Liu, H., Wang, L.L., Zhao, S.J., et al. “Why are pregnant women susceptible to COVID-19? An immunological viewpoint.” J Reprod Immunol 139 (2020): 103122. DOI: 10.1016/j.jri.2020.103122
Chen, S., Liao, E., Shao, Y. “Clinical analysis of pregnant women with 2019 novel coronavirus pneumonia.” J Med Virol (2020). DOI: 10.1002/jmv.25789
Fang, L., Karakiulakis, G., Roth, M. “Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?” Lancet Respir Med 20 (2020): 30116–8.
Guo, W., Li, M., Dong, Y., et al. “Diabetes is a risk factor for the progression and prognosis of COVID-19.” Diabetes Metab Res Rev (2020): e3319. DOI: 10.1002/dmrr.3319
Lee, D.H., Lee, J., Kim, E., et al. “Emergency cesarean section on severe acute respiratory syndrome coronavirus 2 (SARS- CoV-2) confirmed patient.” Korean J Anesthesiol (2020). DOI: 10.4097/kja.20116
Zhou, F., Yu, T., Du, R., et al. “Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective study.” Lancet (2020). DOI: 1016/S0140-6736(20)30566-3
Chen, H., Guo, J., Wang, C., et al. “Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records.” Lancet 395 (2020): 809–15.
Copyright (c) 2020 K. Uzel, I. V. Lakhno
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.